All pacemakers are associated with a risk of cardiac perforation, the agency said, but perforation-related complications appear to be more severe with leadless pacing systems.

Researchers took a fresh look at data from the EMPEROR-Preserved trial, sharing their findings in Circulation.

The analysis included data from more than 85,000 breast cancer patients and an equal number of healthy women with no history of breast cancer. 

Patient outcomes didn't change much when an additional operator was involved—but could this approach impact care in other ways? 

The solution is now cleared as a treatment option for in-stent restenosis in the lower extremity arteries.

Frailty measurements may still provide helpful information in other ways, of course. 

Researchers examined data from the SYNTAX, PRECOMBAT, NOBLE and EXCEL trials, sharing their findings in The Lancet.

The blood-based biomarker was previously associated with worse acute coronary syndrome outcomes. What does it mean for TAVR patients?

Researchers said they hope their findings can shine new light on this "complex relationship."

Researchers have used AI and 3D modeling to identify more than 100 heretofore undiscovered protein complexes and classify more than 700 that were known but until now remained obscure.